...
首页> 外文期刊>Investigative radiology >Can Ex Vivo Magnetic Resonance Imaging of Rectal Cancer Specimens Improve the Mesorectal Lymph Node Yield for Pathological Examination?
【24h】

Can Ex Vivo Magnetic Resonance Imaging of Rectal Cancer Specimens Improve the Mesorectal Lymph Node Yield for Pathological Examination?

机译:直肠癌标本的离体磁共振成像可以改善病理检查的介性淋巴结产量吗?

获取原文
获取原文并翻译 | 示例

摘要

The aim of this study was to use 7 T ex vivo magnetic resonance imaging (MRI) scans to determine the size of lymph nodes (LNs) in total mesorectal excision (TME) specimens and to increase the pathological yield of LNs with MR-guided pathology. Twenty-two fixated TME specimens containing adenocarcinoma were scanned on a 7 T preclinical MRI system with a T1-weighted 3-dimensional gradient echo sequence with frequency-selective lipid excitation (repetition time/echo time, 15/3 milliseconds; resolution, 0.293 mm) and a water-excited 3-dimensional multigradient echo (repetition time, 30 milliseconds; computed echo time, 6.2 milliseconds; resolution, 0.293 mm) pulse sequence.The first series of 11 TME specimens (S1) revealed the number and size of LNs on both ex vivo MRI and histopathology. The second series of 11 TME specimens (S2) was used to perform MR-guided pathology. The number, size, and percentages of yielded LNs of S1 and S2 were compared. In all specimens (22/22), a median number of 34 LNs (interquartile range, 26-34) was revealed on ex vivo MRI compared with 14 LNs (interquartile range, 7.5-21.5) on histopathology (P = 0.003). Mean size of all LNs did not differ between the 2 series (ex vivo MRI: 2.4 vs 2.5 mm, P = 0.267; pathology: 3.6 vs 3.5 mm, P = 0.653). The median percentages of harvested LNs compared with nodes visible on ex vivo MRI per specimen for both series were not significantly different (40% vs 43%, P = 0.718). By using a size threshold of greater than 2 mm, the percentage improved to 71% (S1) and to 78% (S2, P = 0.895). The median number of harvested LNs per specimen did not increase by performing MR-guided pathology (S1, 14 LNs; S2, 20 LNs; P = 0.532). Ex vivo MRI visualizes more LNs than (MR-guided) pathology is able to harvest. Current pathological examination was not further improved by MR guidance. The majority of LNs or LN-like structures visible on ex vivo MRI below 2 mm in size remain unexplained, which warrants a 3-dimensional approach for pathological reconstruction of specimens.
机译:本研究的目的是使用7 T离体磁共振成像(MRI)扫描,以确定总培养基切除(TME)标本的淋巴结(LNS)的大小,并提高LNS与MR引导病理的病理产量。在7吨临床前MRI系统上扫描二十二个固定的TME样品,其具有T1加权三维梯度回波序列,具有频率选择性脂质激发(重复时间/回声时间,15/3毫秒;分辨率,0.293mm )和一种水激发的三维多元影值回声(重复时间,30毫秒;计算回声时间,6.2毫秒;分辨率,0.293mm)脉冲序列。第一个11 TME样本(S1)显示了LNS的数量和大小在exvivo mRI和组织病理学上。第二系列11个TME样本(S2)用于执行MR引导的病理学。比较了S1和S2的所产生的LNS的数量,尺寸和百分比。在所有标本(22/22)中,与14升(四分位数范围,7.5-21.5)的组织病理学(p = 0.003)相比,在exVivo MRI上显示了34个LNS(四分位数范围,26-34)的中值。所有LNS的平均尺寸在2系列之间没有区别(例如:2.4 Vs 2.5 mm,P = 0.267;病理学:3.6 Vs 3.5 mm,P = 0.653)。与两种系列的每种样本对每种样本可见的节点相比,收获LNS的中位数百分比没有显着差异(40%vs 43%,p = 0.718)。通过使用大于2mm的尺寸阈值,百分比改善为71%(S1)和78%(S2,P = 0.895)。通过执行MR引导的病理学(S1,14 LNS; S2,20 LNS; P = 0.532),每样标本的中位数没有增加。前体内MRI可视化比(MR-Guided)病理能够收获的更多LNS。 MR Guidance没有进一步改善目前的病理学检查。大部分LNS或LN样结构在低于2毫米的exvivo mRI上可见,仍然是未解释的,这是标本病理重建的三维方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号